1. Home
  2. PBM vs JAGX Comparison

PBM vs JAGX Comparison

Compare PBM & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • JAGX
  • Stock Information
  • Founded
  • PBM 1994
  • JAGX 2013
  • Country
  • PBM Canada
  • JAGX United States
  • Employees
  • PBM N/A
  • JAGX N/A
  • Industry
  • PBM
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBM
  • JAGX Health Care
  • Exchange
  • PBM NYSE
  • JAGX Nasdaq
  • Market Cap
  • PBM 3.0M
  • JAGX 3.5M
  • IPO Year
  • PBM N/A
  • JAGX N/A
  • Fundamental
  • Price
  • PBM $5.18
  • JAGX $2.54
  • Analyst Decision
  • PBM
  • JAGX Strong Buy
  • Analyst Count
  • PBM 0
  • JAGX 1
  • Target Price
  • PBM N/A
  • JAGX $60.00
  • AVG Volume (30 Days)
  • PBM 66.1K
  • JAGX 87.2K
  • Earning Date
  • PBM 07-07-2025
  • JAGX 08-12-2025
  • Dividend Yield
  • PBM N/A
  • JAGX N/A
  • EPS Growth
  • PBM N/A
  • JAGX N/A
  • EPS
  • PBM 5.24
  • JAGX N/A
  • Revenue
  • PBM N/A
  • JAGX $11,552,000.00
  • Revenue This Year
  • PBM N/A
  • JAGX $22.41
  • Revenue Next Year
  • PBM N/A
  • JAGX $30.00
  • P/E Ratio
  • PBM $0.94
  • JAGX N/A
  • Revenue Growth
  • PBM N/A
  • JAGX 13.93
  • 52 Week Low
  • PBM $2.93
  • JAGX $2.43
  • 52 Week High
  • PBM $701.82
  • JAGX $110.75
  • Technical
  • Relative Strength Index (RSI)
  • PBM 53.67
  • JAGX 27.84
  • Support Level
  • PBM $4.52
  • JAGX $2.43
  • Resistance Level
  • PBM $5.23
  • JAGX $3.30
  • Average True Range (ATR)
  • PBM 0.54
  • JAGX 0.26
  • MACD
  • PBM -0.01
  • JAGX 0.06
  • Stochastic Oscillator
  • PBM 49.93
  • JAGX 7.05

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: